Skip to main content

GLP-1 Agonist Effects

Meaning

The cascade of physiological and metabolic outcomes resulting from the activation of the Glucagon-like Peptide-1 (GLP-1) receptor by a synthetic analog, known as a GLP-1 agonist. These effects are clinically leveraged for the management of type 2 diabetes and obesity, primarily encompassing enhanced glucose-dependent insulin secretion, slowed gastric emptying, and a significant reduction in appetite and food intake. The therapeutic benefit is a multi-systemic improvement in metabolic health.